ProShare Advisors LLC Has $71.29 Million Position in Axon Enterprise, Inc $AXON

ProShare Advisors LLC lessened its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 16.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,338 shares of the biotechnology company’s stock after selling 19,809 shares during the period. ProShare Advisors LLC’s holdings in Axon Enterprise were worth $71,289,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Linden Thomas Advisory Services LLC boosted its position in Axon Enterprise by 3.9% in the 3rd quarter. Linden Thomas Advisory Services LLC now owns 1,071 shares of the biotechnology company’s stock valued at $769,000 after buying an additional 40 shares during the last quarter. SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co lifted its stake in shares of Axon Enterprise by 70.0% during the third quarter. SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co now owns 2,829 shares of the biotechnology company’s stock valued at $2,030,000 after acquiring an additional 1,165 shares during the period. Oppenheimer Asset Management Inc. increased its position in Axon Enterprise by 10.2% in the third quarter. Oppenheimer Asset Management Inc. now owns 6,648 shares of the biotechnology company’s stock worth $4,771,000 after purchasing an additional 618 shares during the period. Candriam S.C.A. increased its position in Axon Enterprise by 2.2% in the third quarter. Candriam S.C.A. now owns 5,844 shares of the biotechnology company’s stock worth $4,194,000 after purchasing an additional 128 shares during the period. Finally, New York Life Investment Management LLC raised its holdings in Axon Enterprise by 3.6% during the 3rd quarter. New York Life Investment Management LLC now owns 11,446 shares of the biotechnology company’s stock worth $8,214,000 after purchasing an additional 402 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on AXON shares. Royal Bank Of Canada began coverage on shares of Axon Enterprise in a research note on Monday, November 17th. They issued an “outperform” rating and a $860.00 target price on the stock. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a report on Wednesday, November 5th. The Goldman Sachs Group dropped their target price on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a research report on Wednesday, November 5th. Piper Sandler reduced their price target on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Finally, William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $805.71.

Insiders Place Their Bets

In other news, CAO Jennifer H. Mak sold 1,134 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $600.00, for a total transaction of $680,400.00. Following the completion of the sale, the chief accounting officer owned 13,740 shares of the company’s stock, valued at $8,244,000. This represents a 7.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $551.92, for a total transaction of $5,519,200.00. Following the completion of the sale, the chief executive officer directly owned 3,110,997 shares in the company, valued at $1,717,021,464.24. This represents a 0.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 48,040 shares of company stock worth $27,249,338 in the last three months. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Stock Up 4.7%

NASDAQ:AXON opened at $433.77 on Tuesday. Axon Enterprise, Inc has a 1 year low of $396.41 and a 1 year high of $885.91. The stock has a 50-day moving average price of $566.28 and a two-hundred day moving average price of $655.91. The stock has a market cap of $34.23 billion, a price-to-earnings ratio of 137.27, a PEG ratio of 12.48 and a beta of 1.48. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.